神経血管デバイス市場：タイプ別、用途別-2025-2030年の世界予測

神経血管デバイス市場の2023年の市場規模は30億米ドルで、2024年には32億3,000万米ドルに達すると予測され、CAGR 7.79％で成長し、2030年には50億8,000万米ドルに達すると予測されています。

神経血管デバイス市場には、脳卒中、動脈瘤、動静脈奇形などの症状を含む中枢神経系（CNS）内の血管障害を診断・治療するために設計されたさまざまな技術が含まれます。これらの機器は、高齢化社会と生活習慣に関連した危険因子により、中枢神経系血管疾患の有病率が増加しているため、必要不可欠なものとなっています。一般的な用途としては、低侵襲手技、塞栓術、ステント留置術、血栓除去術などがあり、主に専門的な神経治療が必要な病院、神経科クリニック、外来手術センターで利用されています。主な成長促進要因としては、神経血管障害の早期介入に対する意識の高まりとともに、AI統合画像システム、ロボット工学などの技術進歩が挙げられます。アジア太平洋とラテンアメリカの新興市場は、より広範なヘルスケアへのアクセスと経済成長に後押しされ、成長機会が拡大しています。こうした機会を生かすための提言としては、戦略的パートナーシップ、現地製造への投資、多様な地域の医療インフラに対応した個別化医療ソリューションなどがあります。

その潜在性にもかかわらず、市場は厳しい規制要件、先端技術開拓に伴う高コスト、神経インターベンション手技の訓練を受けた熟練ヘルスケア専門家の不足などの課題に直面しています。さらに、発展途上地域における経済格差が、高度な神経血管治療を行う上での経済的障壁となっています。技術革新と研究については、AIと機械学習による機器精度の向上、生体吸収性ステントの開発、非侵襲的診断技術の改善などが重点分野となります。遠隔神経学の革新は、遠隔地における質の高い治療へのアクセスを拡大する可能性もあります。この業界は、急速な技術進歩や頻繁な合併・買収を特徴とし、継続的な製品強化や市場拡大に注力しており、ダイナミックで適度な競争を維持しています。デジタルヘルスプラットフォームと、エビデンスに基づく実臨床のアウトカムに注力する企業が、進化する状況の中で確固たる地位を築き、最終的に患者ケアの向上と市場成長につながる可能性を示唆しています。

市場力学：急速に進化する神経血管デバイス市場の主要市場インサイトを公開

神経血管デバイス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 神経疾患の発生率の増加
  • 高血圧、飲酒、喫煙の有病率の増加
  • 低侵襲手術に対する需要の高まり
• 市場抑制要因
  • 熟練した神経外科医の不足
• 市場機会
  • 神経血管デバイスに関する技術進歩の急増
  • 血栓除去技術の進歩の採用
• 市場の課題
  • 神経血管手術の処置コストの高さ

ポーターの5つの力：神経血管デバイス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：神経血管デバイス市場における外部からの影響の把握

外部マクロ環境要因は、神経血管デバイス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析神経血管デバイス市場における競合情勢の把握

神経血管デバイス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス神経血管デバイス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、神経血管デバイス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨神経血管デバイス市場における成功への道筋を描く

神経血管デバイス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 神経疾患の発生率の増加
    • 高血圧、アルコール摂取、喫煙の増加
    • 低侵襲手術の需要増加
  • 抑制要因
    • 熟練した脳神経外科医の不足
  • 機会
    • 神経血管デバイスに関する技術進歩の急増
    • 血栓除去技術の進歩の採用
  • 課題
    • 神経血管手術の高額な手術費用
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 神経血管デバイス市場：タイプ別

• 頸動脈ステントシステム
• 脳動脈瘤および動静脈奇形血管内塞栓術システム
• 脳血栓除去装置
• 動脈瘤用フローダイバータ
• 頭蓋内ステントシステム

第7章 神経血管デバイス市場：用途別

• 脳動脈瘤
• 脳動脈狭窄症
• 脳卒中

第8章 南北アメリカの神経血管デバイス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の神経血管デバイス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの神経血管デバイス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Balt USA LLC
• Evasc Medical Systems Corp.
• Integer Holdings Corporation
• Johnson & Johnson Services, Inc.
• Kaneka Corp.
• Medtronic PLC
• MicroPort Scientific Corporation
• Penumbra, Inc.
• Phenox GmbH
• Rapid Medical Ltd.
• Sensome
• Stryker Corporation
• Terumo Corporation

LIST OF FIGURES

• FIGURE 1. NEUROVASCULAR NEUROLOGY DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. NEUROVASCULAR NEUROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. NEUROVASCULAR NEUROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NEUROVASCULAR NEUROLOGY DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NEUROVASCULAR NEUROLOGY DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY CAROTID ARTERY STENTING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL ANEURYSM & AVM ENDOVASCULAR EMBOLIZATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL THROMBECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTER FOR ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INTRACRANIAL STENT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL ARTERY STENOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STROKE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 34. AUSTRALIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. AUSTRALIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. CHINA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. CHINA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. INDIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. INDIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. INDONESIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. INDONESIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. JAPAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. JAPAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. MALAYSIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. MALAYSIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. PHILIPPINES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. PHILIPPINES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. SINGAPORE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. SINGAPORE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. SOUTH KOREA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. SOUTH KOREA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. TAIWAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. TAIWAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. THAILAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. THAILAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. VIETNAM NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. VIETNAM NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 61. DENMARK NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. DENMARK NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. EGYPT NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. EGYPT NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. FINLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. FINLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. FRANCE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. FRANCE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. GERMANY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. GERMANY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. ISRAEL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. ISRAEL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. ITALY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. ITALY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. NETHERLANDS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. NETHERLANDS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. NIGERIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. NIGERIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. NORWAY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. NORWAY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. POLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. POLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. QATAR NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. QATAR NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. RUSSIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. RUSSIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SAUDI ARABIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SAUDI ARABIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. SPAIN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SPAIN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. SWEDEN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. SWEDEN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. SWITZERLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. SWITZERLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. TURKEY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. TURKEY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. UNITED ARAB EMIRATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. UNITED ARAB EMIRATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. UNITED KINGDOM NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. UNITED KINGDOM NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. NEUROVASCULAR NEUROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 104. NEUROVASCULAR NEUROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Neurovascular Neurology Devices Market was valued at USD 3.00 billion in 2023, expected to reach USD 3.23 billion in 2024, and is projected to grow at a CAGR of 7.79%, to USD 5.08 billion by 2030.

The neurovascular neurology devices market encompasses a range of technologies designed to diagnose and treat vascular disorders within the central nervous system (CNS), including conditions such as stroke, aneurysms, and arteriovenous malformations. These devices are vital due to the increasing prevalence of CNS vascular diseases, driven by an aging population and lifestyle-related risk factors. Common applications include minimally invasive procedures, embolization, stenting, and thrombectomy, utilized primarily by hospitals, neurology clinics, and ambulatory surgical centers where specialized neurological care is required. Key growth drivers include technological advancements, such as AI-integrated imaging systems and robotics, alongside rising awareness about early intervention in neurovascular disorders. Opportunities are expanding with emerging markets in Asia-Pacific and Latin America, propelled by broader healthcare access and economic growth. Recommendations to capitalize on these opportunities include strategic partnerships, investment in local manufacturing, and personalized medical solutions catering to diverse regional health infrastructures.

Despite its potential, the market faces challenges including stringent regulatory requirements, high costs associated with advanced technology development, and a shortage of skilled healthcare professionals trained in neurointerventional procedures. Additionally, the economic discrepancies in developing regions pose financial barriers to advanced neurovascular care. For innovation and research, focus areas include enhancing device accuracy through AI and machine learning, developing bioabsorbable stents, and improving non-invasive diagnostic techniques. Innovations in tele-neurology could also expand access to quality care in remote areas. The industry remains dynamic and moderately competitive, characterized by rapid technological advancements and frequent mergers or acquisitions, focusing on continual product enhancement and market expansion. Insight into this nature suggests that companies focusing on digital health platforms and real-world, evidence-based outcomes could position themselves strongly in the evolving landscape, ultimately leading to enhanced patient care and market growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neurovascular Neurology Devices Market

The Neurovascular Neurology Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increase in the incidence of neurological disorders
  • Increasing prevalence of hypertension, alcohol consumption, and smoking
  • Rising demand for minimally invasive surgical procedures
• Market Restraints
  • Lack of skilled neurosurgeons
• Market Opportunities
  • Surge in technological advancements related to neurovascular devices
  • Adoption of advances in thrombectomy technologies
• Market Challenges
  • High procedural cost of neurovascular surgeries

Porter's Five Forces: A Strategic Tool for Navigating the Neurovascular Neurology Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neurovascular Neurology Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neurovascular Neurology Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neurovascular Neurology Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neurovascular Neurology Devices Market

A detailed market share analysis in the Neurovascular Neurology Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neurovascular Neurology Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neurovascular Neurology Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neurovascular Neurology Devices Market

A strategic analysis of the Neurovascular Neurology Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neurovascular Neurology Devices Market, highlighting leading vendors and their innovative profiles. These include Balt USA LLC, Evasc Medical Systems Corp., Integer Holdings Corporation, Johnson & Johnson Services, Inc., Kaneka Corp., Medtronic PLC, MicroPort Scientific Corporation, Penumbra, Inc., Phenox GmbH, Rapid Medical Ltd., Sensome, Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Neurovascular Neurology Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Carotid Artery Stenting System, Cerebral Aneurysm & AVM Endovascular Embolization Systems, Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm, and Intracranial Stent Systems.
• Based on Application, market is studied across Cerebral Aneurysm, Cerebral Artery Stenosis, and Stroke.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increase in the incidence of neurological disorders
    • 5.1.1.2. Increasing prevalence of hypertension, alcohol consumption, and smoking
    • 5.1.1.3. Rising demand for minimally invasive surgical procedures
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of skilled neurosurgeons
  • 5.1.3. Opportunities
    • 5.1.3.1. Surge in technological advancements related to neurovascular devices
    • 5.1.3.2. Adoption of advances in thrombectomy technologies
  • 5.1.4. Challenges
    • 5.1.4.1. High procedural cost of neurovascular surgeries
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Neurovascular Neurology Devices Market, by Type

• 6.1. Introduction
• 6.2. Carotid Artery Stenting System
• 6.3. Cerebral Aneurysm & AVM Endovascular Embolization Systems
• 6.4. Cerebral Thrombectomy Devices
• 6.5. Flow Diverter for Aneurysm
• 6.6. Intracranial Stent Systems

7. Neurovascular Neurology Devices Market, by Application

• 7.1. Introduction
• 7.2. Cerebral Aneurysm
• 7.3. Cerebral Artery Stenosis
• 7.4. Stroke

8. Americas Neurovascular Neurology Devices Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Neurovascular Neurology Devices Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Neurovascular Neurology Devices Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Balt USA LLC
• 2. Evasc Medical Systems Corp.
• 3. Integer Holdings Corporation
• 4. Johnson & Johnson Services, Inc.
• 5. Kaneka Corp.
• 6. Medtronic PLC
• 7. MicroPort Scientific Corporation
• 8. Penumbra, Inc.
• 9. Phenox GmbH
• 10. Rapid Medical Ltd.
• 11. Sensome
• 12. Stryker Corporation
• 13. Terumo Corporation